Expression of CK-19 Immunomarker in Thyroid Neoplasm and its Association with Histopathology

Main Article Content

Anindita Sarkar
SM Asafudullah
Shah Md Badruddoza
Rebeka Sultana
Sunandita Sarkar
Sujit Kumar Sarker

Abstract

Background & Objective: Early and accurate diagnosis of thyroid neoplasm is of utmost significance for prolongation of patient survival. A panel of immunomarkers has been tested to overcome the limitation of histopathology. CK-19 is a commonly used immunomarker among them. This study was undertaken to evaluate the diagnostic accuracy of CK-19 in thyroid neoplasm. Methods & Materials: This cross-sectional study was conducted in the Department of Pathology, Rajshahi Medical College, over a period of two years, from July 2017 to June 2019. A total of 44 tissue blocks of histologically confirmed thyroid neoplasm were included in this study. Then immunohistochemistry was done for CK-19 from a significant paraffin-embedded block. Result: In the present study, diffuse and strong positivity of CK-19 was found in papillary thyroid carcinoma (PTC), followed by focal positivity in follicular(FC) and medullary carcinoma (MC). A negative staining pattern was found in all cases of follicular adenoma (FA). The sensitivity and specificity of CK-19 were found to be high in the case of PTC, respectively, 88% and 92%.CK-19 expression was highly specific in differentiating malignant from benign thyroid tumors (100%). Conclusion: The study concluded that CK 19 is a highly sensitive and specific marker in papillary thyroid carcinoma. Diffuse and strong positivity is characteristic of PTC, which can be used in diagnosis with equivocal morphological appearance.

Article Details

How to Cite
1.
Sarkar A, SM Asafudullah, Shah Md Badruddoza, Rebeka Sultana, Sarkar S, Sarker SK. Expression of CK-19 Immunomarker in Thyroid Neoplasm and its Association with Histopathology. TAJ. 2022;35(1):1-6. doi:10.70818/gb119c55
Section
Articles

How to Cite

1.
Sarkar A, SM Asafudullah, Shah Md Badruddoza, Rebeka Sultana, Sarkar S, Sarker SK. Expression of CK-19 Immunomarker in Thyroid Neoplasm and its Association with Histopathology. TAJ. 2022;35(1):1-6. doi:10.70818/gb119c55

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.